We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAB:ASXNational Australia Bank Limited Analysis

Data as of 2026-05-18 - not real-time

A$36.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

National Australia Bank is trading at $36.32, well below its 20‑day ($38.96), 50‑day ($42.29) and 200‑day ($42.72) simple moving averages, indicating a bearish technical backdrop. RSI is at 23.4, suggesting the stock is oversold, while the MACD remains in a bearish configuration. The price sits just above the identified support level of $36.03, with resistance near $41.38, offering limited upside of roughly 6% based on the upside/downside metric. Fundamentally, the bank posts a solid operating margin of 52% and a profit margin of 30%, but operating cash flow is negative ($‑24.1 bn) and impairment costs of A$706 m have weighed on earnings. The forward PE of 14.6 is below the current PE of 18.2 and the industry average of 16.5, hinting at valuation compression. However, the PE is still higher than peers and the high dividend yield of 4.68% comes with an 85% payout ratio, raising questions about sustainability given the cash flow pressure. Analyst consensus rates the stock as a "hold" with a mean target price of $38.65, modestly above the current level. Volatility is elevated at 26.6% over the past 30 days, but beta is low at 0.28, indicating limited market‑wide price swings. Recent news highlights strong headwinds and a 26% share price decline from recent peaks, driven by higher impairment expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicates oversold conditions
  • Price hovering just above support
  • Recent impairment cost concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE discount to industry
  • Attractive dividend yield
  • Low beta suggesting stable price behavior

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Consistent dividend payout
  • Stable earnings margins
  • Ongoing regulatory and macroeconomic uncertainty

Key Metrics & Analysis

Financial Health

Profit Margin29.67%
P/E Ratio18.2
ROE9.91%
ROA0.55%
P/B Ratio1.8
Op. Cash FlowA$-24084000768
Industry P/E16.5

Technical Analysis

TrendBearish
RSI23.4
SupportA$36.03
ResistanceA$41.38
MA 20A$38.96
MA 50A$42.29
MA 200A$42.72
MACDBearish
VolumeIncreasing
Fear & Greed Index88.39

Valuation

Target PriceA$38.65
Upside/Downside6.41%
GradeFair
TypeValue
Dividend Yield4.68%

Risk Assessment

Beta0.28
Volatility26.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.